The National Cancer Control Authority in Libya has announced that more than 4,000 cancer patients have fully recovered, thanks to local medical efforts, in what is being hailed as a major milestone in the country’s battle against the disease.
Speaking at the opening of the Libyan International Conference on Oncology and Radiotherapy, the authority’s head, Dr Haider Al-Sayah, revealed that over 4,000 patients had undergone nuclear imaging scans in Libya within the past year. He added that cancer treatments had begun arriving in the country, describing the step as a breakthrough in providing local, dignified care for cancer patients.
“World-class medications have arrived for Libyan citizens,” said Dr Al-Sayah. “We can now reassure every cancer patient that high-quality treatment is available at home.”
The new medication shipments are part of an official procurement programme managed by the National Authority, with supplies sourced directly from reputable global manufacturers.
Al-Sayah also highlighted progress in radiotherapy services and nuclear scanning, which have now been localised in Libya. He called the achievement a “national success” and a vital part of ongoing efforts to ensure Libyans receive treatment without needing to travel abroad.
He noted that the digital “Moharib” (Fighter) system has recorded and diagnosed over 24,000 cancer patients nationwide. Alarmingly, around 17,000 of these patients were previously undocumented and not registered in Libya’s healthcare system.
Al-Sayah said the international oncology conference was attended by 13 foreign experts, who came to share their medical expertise and support the country’s oncology efforts.
The event underscored the National Authority’s growing role in cancer diagnosis, treatment, and international collaboration.
